✦ LIBER ✦

Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin

✍ Scribed by C. PRANTERA; H. LOCHS; M. CAMPIERI; M. L. SCRIBANO; G. C. STURNIOLO; F. CASTIGLIONE; M. COTTONE

Book ID: 108604520
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 155 KB
Volume: 23
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2006.02879.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of olsalazine for active Crohn's disease

✍ J. P. Wright; Dr. D. P. Jewell; R. Modigliani; H. Malchow 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 486 KB 👁 2 views

Olsalazine, consisting of two salicylate radicals linked by an azo-bond, is effective in the treatment of active ulcerative colitis. To test its effect in patients with mild to moderate attacks of Crohn's disease, the International Organization for the Study of Inflammatory Bowel Disease (IOIBD) des

Efficacy of rifaximin in the treatment o

Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial

✍ C. PAPI; A. CIACO; M. KOCH; L. CAPURSO 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 528 KB

Clinical trial: vitamin D3 treatment in

Clinical trial: vitamin D3 treatment in Crohn’s disease – a randomized double-blind placebo-controlled study

✍ S. P. Jørgensen; J. Agnholt; H. Glerup; S. Lyhne; G. E. Villadsen; C. L. Hvas; L 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of lenalidomide in the treatment of moderately severe active Crohn’s disease

✍ J. C. MANSFIELD; M. PARKES; A. B. HAWTHORNE; A. FORBES; C. S. J. PROBERT; R.C. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 563 KB

Treatment of early Rheumatoid Arthritis

Treatment of early Rheumatoid Arthritis with minocycline or placebo. Results of a Randomized, double-blind, placebo-controlled trial

✍ James R. O'Dell; Claire E. Haire; William Palmer; Walter Drymalski; Steven Wees; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 692 KB

Rifaximin for the treatment of active po

Rifaximin for the treatment of active pouchitis: A randomized, double-blind, placebo-controlled pilot study

✍ Kim L. Isaacs; Robert S. Sandler; Maria Abreu; Michael F. Picco; Stephen B. Hana 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 2 views

## Background: The efficacy of the nonabsorbable antibiotic rifaximin in patients with active acute or chronic pouchitis is unknown. ## Methods: We performed a placebo-controlled pilot trial to evaluate the efficacy and safety of rifaximin in patients with active pouchitis. eighteen patients with